Interleukin-2 induces peroxide production by primed normodense eosinophils of patients with asthma

Allergy and Asthma Proceedings

Volumn 24, Issue 1, 2003, Pages 27-33

  Conesa, Angela ^a,c   Tassinari, Paolo ^a   Aldrey, Oscar ^a   Taylor, Peter ^b   Bianco, Nicolas E ^a   De Sanctis, Juan B ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^c Institute de Immunologîa   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; HYDROGEN PEROXIDE; IMMUNOGLOBULIN E; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ANTIBODY; ISOPROTEIN; RECOMBINANT INTERLEUKIN 2; BIOLOGICAL MARKER; CARCINOGEN; CD69 ANTIGEN; COLORING AGENT; FC RECEPTOR; INTERLEUKIN 2; LEUKOCYTE ANTIGEN; MEMBRANE ANTIGEN; PEROXIDE; PHORBOL 13 ACETATE 12 MYRISTATE; T LYMPHOCYTE ANTIGEN; TRYPAN BLUE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL ISOLATION; CELL SURFACE; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; EOSINOPHIL; EXTRINSIC ASTHMA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; KINETICS; PROTEIN FUNCTION; RESPIRATORY BURST; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ADOLESCENT; ASTHMA; BIOSYNTHESIS; BLOOD; CELL SURVIVAL; COMPARATIVE STUDY; FEMALE; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; STIMULATION; TIME; VENEZUELA;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIGENS, SURFACE; ASTHMA; BIOLOGICAL MARKERS; CARCINOGENS; CELL SURVIVAL; COLORING AGENTS; EOSINOPHILS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-2; MALE; PEROXIDES; RECEPTORS, IGG; RESPIRATORY BURST; STIMULATION, CHEMICAL; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS; TRYPAN BLUE; VENEZUELA;

EID: 0037823426     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Ackerman S. Eosinophils: biologic and clinical aspects in allergy and inflammation. In Clinical Immunology. Principles and Practice. Rich RR (Ed)., St. Louis, MO: Mosby-Year Book, Inc., 431-438, 1996.
2. Kita H, Adolphson C, and Gliench G. Biology of Eosinophils. In Allergy. Principles and Practice. Middlenton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, and Busse WW (Eds). St. Louis, MO: Mosby-Year Book, Inc., 242-261, 1998.
3. Lacy P, and Moqbel R. Eosinophil cytokines. Chem Immunol 76:134-155, 2000.
4. 2+ independent and accompanied by induction of tyrosine kinase activity. J Leukoc Biol 53:347-353, 1993.
5. Morel F, Doussiere J, and Vignais P. The superoxide-generating of phagocytic cells. Physiological, molecular, and pathological aspects. Eur J Biochem 201:523-546, 1991.
6. Horie S, Gleich G, and Kita H. Cytokines directly induce degranulation and superoxide production from human eosinophils. J Allergy Clin Immunol 98:371-381, 1996.
7. Murray B, Resnick M, and Weller P. Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol 8:349-355, 1993.
8. Sedgwick J, Frick W, Sondel P, et al. The appearance of hypodense eosinophils during interleukin-2 treatment. J Allergy Clin Immunol 85:557-566, 1990.
9. Honenstein R, Admon D, Solomon A, et al. Interleukin-2 activates human peripheral blood eosinophils. Cell Immunol 210:116-124, 2001.
10. Yamaguchi Y, Suda T, Shiozaki H, et al. Role of IL-5 in IL-2-induced eosinophilia. In vivo and in vitro expression of IL-5 mRNA by IL-2. J Immunol 145:873-880, 1990.
11. Sugamura K, Asao H, Kondo M, et al. The common γ chain for multiple cytokine receptors. Adv Immunol 59:225-269, 1995.
12. Plumas J, Gruart V, Aldebert D, et al. Human eosinophils from hypereosinophilic patients spontaneously express the p55 but not the p75 IL-2 receptor subunit. Eur J Immunol 21:1265-1270, 1991.
13. Conesa A, Tassinari P, Rivera H, et al. Hypodense eosinophils. Characterization of surface molecule expression. Allergy Asthma Proc In press.
14. Ebisawa M, Schteimer R, Bickel C, et al. Phenotyping of purified human peripheral blood eosinophils using the blind panel mAb. In Leukocyte Typing V: White Cell Differentiation Antigens. Schlossman S (Ed). New York: Oxford University Press, 1995.
15. Rand T, Silberstein D, Kornfeld H, et al. Human eosinophils express functional interleukin 2 receptors. J Clin Invest 88:825-832, 1991.
16. Gärtner I. Separation of human eosinophils in density gradients of polyvinyl pyrrolidone-coated silica gel (Percoll). Immunology 40:133-136, 1980.
17. Day R. Eosinophils cell separation from human peripheral blood. Immunology 18:955-959, 1970.
18. Davis B. Oxidative burst methods. In Handbook of Cytometry Method. Robinson JP (Ed). New York: A.R. Liss, 146-154, 1993.
19. Toro F, Conesa A, García A, et al. Increased peroxide production by polymorphonuclear cells of chronic hepatitis C virus-infected patients. Clin Immunol Immunopatol 88:169-175, 1998.
20. Lara L, Rivera H, Perez C, et al. Low density lipoprotein receptor expression and function in human polimorphonuclear leukocytes. Clin Exp Immunol 107:205-212, 1996.
21. Howard M, Miyajima A, and Coffman R. T cell-derived cytokines and their receptors. In Fundamental Immunology. Paul WE (Ed), New York: Raven Press, 763-800, 1993.
22. Hassan N, Campbell D, and Douglas S. Phorbol myristate acetate induced oxidation of 2′,7′-dichlorofluorescein by neutrophils from patients with chronic granulomatous disease. J Leukoc Biol 43:317-322, 1988.
23. Woschnagg C, Garcia R, and Rak S. IL-5 priming of the PMA-induced oxidative metabolism of human eosinophils from allergic and normal subjects during pollen season. Clin Exp Allergy 31:555-564, 2001.
24. Dombrowicz D, Woerly G, and Capron M. IgE receptors on human eosinophils. Chem Immunol 76:63-76, 2000.
25. 2+ rise. Eur J Clin Invest 25:25-31, 1995.
26. Tachimoto H, and Bochner B. The surface phenotype of human eosinophils. Chem Immunol 76:45-62, 2000.
27. Elser J, and Kapp A. Regulation and modulation of eosinophil effector functions. Allergy 54:15-26, 1999.